Taro-Zoledronic acid injection drug recalled Drug used for osteoporosis and Paget's disease recalled because it may contain particulate matter Bladder Cancer Canada addresses resolution of BCG shortage for bladder cancerPatients with nonmuscle-invasive bladder cancer should receive full doses of BCG. New brand of BCG now available in Canada for treatment of bladder cancer Availability of Verity-BCG will help overcome years of intravesical BCG shortage, dose rationing and dose reductions. Amid Canadian shortage, U.S. approves generic EpiPen The U.S. approval comes as Canadian pharmacies deal with a potential shortage of EpiPens this month U.S. approved a whopping 45 first-of-a-kind drugs in 2015 Annual tally country's highest level in 19 years. Drug executives seeking approval for female libido pill previously ran afoul of FDA rules Marketing push made misleading, unsupported statements about the benefits of testosterone therapy while downplaying risks. NACDS Marketplace: Coming soon to a drugstore near you NACDS Marketplace showcases health and beauty trends. Taro recalls one lot of Docusate Sodium Notice due to possible bacterial contamination with Cronobacter (Enterobacter) sakazakii. Ontario lays charges against pharmacies, wholesalers and generic firms Ontario takes legal action against a number of parties after forensic audits revealed wide-scale fraud against the ODB plan. 1